Nuchev Pty Ltd · ASX:NUC

Nuchev Pty — Wilsons Rapid Insights Conference (May 2021)

14 slides from Nuchev Pty's conference presentation, May 26, 2021

  1. Slide 1: Wilsons Rapid Insights Conference – Nuchev Limited

    For personal use only Wilsons Rapid Insights Conference Nuchev Limited 26 May 2021

  2. Slide 2: An Introduction to Nuchev – Food for a Better Life

    An Introduction to Nuchev – Food for a Better Life For personal use only Established in 2013 ASX listing Dec 2019 Founded by CEO Ben Dingle, from four Major milestone in company’s growth generations of dairy farming strategy, following successful IPO Experts in goat‐milk infant formula Capital raise

  3. Slide 3: Post COVID impact

    Post COVID impact For personal use only China & Shift from Cycling pantry Australia Supply Chain Regulatory Daigou to stocking Trade Online Relations 2

  4. Slide 4: Why Goat Formula?

    WHY GOAT Formula? For personal use only AIDS DIGESTION – CLOSER TO GROWING ASSISTS WITH BREAST MILK FASTER THAN TOTAL ALLERGIES, THAN COWS MILK INFANT FORMULA SENSITIVITIES AND LACTOSE INTOLERANCE Source : Euromonitor 2020

  5. Slide 5: Why Oli6?

    Why Oli6 ? ® For personal use only FAST GROWING NO.2 GROWTH ONLY BRAND GOAT INFANT FORMULA BRAND AHEAD OF THE WITH BRAND IN AUSTRALIAN CATEGORY HUMAN MILK PHARMACY OLIGOSACCHIRIDES & TMall FSS NO.3 BACKED BY SCIENCE Source : Pharmacy Data Dec 20 and Smartpath MAT Feb 2021

  6. Slide 6: Goat Infant Formula in China continues to grow despite COVID-19 and AU/CN trade relations

    Goat Infant Formula in China continues to grow despite COVID‐19 and AU/CN trade relations For personal use only Total Addressable Goat Infant Formula Market Goat is growing faster than total infant formula is valued at 16B RMB in China market and Oli6® continues to grow ahead of the CBEC market +25%

  7. Slide 7: Focus on CBEC sales through sub channel strategy

    Focus on CBEC sales through sub channel strategy For personal use only Retailing Coles & CW FSS TDI & JD Nuchev CBEC O2O Others Export C2C 6

  8. Slide 8: Establishing the brand as experts in goat nutrition

    Establishing the brand as experts in goat nutrition For personal use only • Unique prebiotic blend‐ Symbioli∞™ • Scientifically researched and proven to assist with gut health, digestion and immunity • 8 prebiotics including Omega 3 & Omega 6 • Only brand with HMOs – human milk oligosacchirides that

  9. Slide 9: Global first in Goat Infant Formula – adding HMO's

    Global first in Goat Infant Formula – adding HMO’s The global Human Milk Oligosaccharides (HMO) market size is projected to reach USD 1.5B by 2026 at a CAGR of +30.6% during 2021‐2026. For personal use only • Increased concerns regarding gut health • HMO’s act as a prebiotic in the human body and he

  10. Slide 10: Oli6's unique formulation backed by science meeting consumers and shoppers needs

    Oli6®’s unique formulation backed by science meeting consumers and shoppers needs For personal use only 6 PrebioticOligos from 2-FL & LNnT Oli6® Goat’s Milk HMOs are the third most abundant Scientific research shows that Oli6 ingredient in Human Milk has 6 prebiotics that have the same prebiotic ben

  11. Slide 11: Building the Oli6 brand

    Building the Oli6® brand For personal use only • Build brand name recognition ‘Oli’ • Leverage equity of Celebrity KOL & KOC • Position Oli6® as the leaders in goat nutrition • Connect brand with core benefit of aiding digestion 10

  12. Slide 12: Secure scaleable supply chain

    Secure scaleable supply chain Flexible supply chain across strategic suppliers and outsourced processors For personal use only Security of Raw Stage 1 - Outsourced Stage 2 - Outsourced Sales Distribution Ingredient Supply Manufacturing (base) Manufacturing (B&C) Channels • Long term strategic • Long

  13. Slide 13: For personal use only

    For personal use only

  14. Slide 14: Disclaimer

    Disclaimer For personal use only This presentation is provided by Nuchev Limited (ACN 163 225 090) (Nuchev) to provide summary information about Nuchev and its respective subsidiaries (together, the Group). Statements in this presentation are made as at the date of the presentation and the informati

Nuchev — Wilsons Rapid Insights Conference (May 2021) on 6ix